[Preoperative chemotherapy combined with postoperative radiotherapy in the treatment of non-small-cell lung cancer.].
To evaluate the clinical therapeutic effect of preoperative chemotherapy combined with postoperative radiotherapy in the treatment of stage II to III non-small-cell lung cancer. From June 1990 to December 1993 , 50 patients with stage II to III non-small-cell lung cancer received preoperative chemotherapy and postoperative radiotherapy as study group , and another 50 patients only undergoing surgical treatment as control. The resective rate and 5-year survival rate were 92 % and 42 % in the study group , while in control group they were 84 % and 24 %. There was significant difference in 5-year survival rate between the two group ( P < 0. 05) . The lymphatic metastatic rate in the study group (45. 7 %) was significantly lower than that in the control group (78. 6 %) ( P < 0. 05) . Preoperative chemotherapy combined with postoperative radiotherapy might be helpful to improve the long-term survival rate of the patients with non-small-cell lung cancer.